1. Home
  2. CRNC vs BNTC Comparison

CRNC vs BNTC Comparison

Compare CRNC & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cerence Inc.

CRNC

Cerence Inc.

SELL

Current Price

$8.90

Market Cap

349.6M

Sector

Technology

ML Signal

SELL

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$8.61

Market Cap

313.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNC
BNTC
Founded
2020
1995
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
349.6M
313.9M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
CRNC
BNTC
Price
$8.90
$8.61
Analyst Decision
Hold
Strong Buy
Analyst Count
5
7
Target Price
$10.75
★ $24.33
AVG Volume (30 Days)
★ 647.1K
192.6K
Earning Date
11-18-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 96.95
6.67
EPS
★ N/A
N/A
Revenue
★ $251,781,000.00
N/A
Revenue This Year
$24.19
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$5.85
$8.51
52 Week High
$13.28
$16.76

Technical Indicators

Market Signals
Indicator
CRNC
BNTC
Relative Strength Index (RSI) 62.36 31.76
Support Level $7.64 $8.52
Resistance Level $9.19 $14.09
Average True Range (ATR) 0.35 0.64
MACD 0.12 -0.00
Stochastic Oscillator 75.53 22.04

Price Performance

Historical Comparison
CRNC
BNTC

About CRNC Cerence Inc.

Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

Share on Social Networks: